XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 101 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $732,000 | +9.1% | 162,321 | +19.0% | 0.01% | 0.0% |
| Q4 2020 | $671,000 | +219.5% | 136,397 | +284.7% | 0.01% | +200.0% |
| Q3 2020 | $210,000 | +47.9% | 35,451 | -33.7% | 0.00% | 0.0% |
| Q2 2020 | $142,000 | -5.3% | 53,443 | -30.4% | 0.00% | 0.0% |
| Q1 2020 | $150,000 | – | 76,760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|